Cite
HARVARD Citation
Nagase, M. et al. (2020). Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non‐Small Cell Lung Cancer. CPT: pharmacometrics & systems pharmacology. pp. 143-152. [Online].